Duloxetine HCL DR Capsules
Award Notice Posted
- Solicitation number
- SPE2D2-26-D-0008
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Awarded
- to Golden State Medical Supply, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- SPE2D2-26-D-0008 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Salcete Goa 40372 India
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
Defense Logistics Agency Troop Support Medical awarded contract SPE2D2-26-D-0008 to Golden State Medical Supply, Inc. for $133.18 million to supply Duloxetine HCL delayed-release capsules in eight formulations across five contract years (base year plus four option years), with award made on July 13, 2026.
The contract supplies 20mg, 30mg, 40mg, and 60mg capsules in 30-, 60-, 90-, and 1,000-count bottles to the DLA Pharmaceutical Prime Vendors program for distribution to DLA and VA pharmaceutical prime vendors. Unit pricing is fixed at $5.19 to $150.00 per bottle across all contract periods; all quantities are estimates subject to FAR 52.216-21. The active pharmaceutical ingredient is manufactured by Lupin Limited at its facility in Verna, Goa, India; packaging and secondary operations are performed by Golden State Medical Supply in Camarillo, California. The award followed unrestricted competition. Payment terms are Net 30 days per Amendment P00001, effective July 14, 2026.
Notice text
SPE2D2-26-D-0008 Duloxetine HCL DR Award
Awarded contract SPE2D2-26-D-0008 to GOLDEN STATE MEDICAL SUPPLY, INC. for 133180441.30 on 2026-07-13.
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Duloxetine HCL DR Capsules | Solicitation | |
| Duloxetine HCL DR Capsules | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity